Background: Glial fibrillary acidic protein (GFAP) is a brain‑specific astroglial protein that is released into the blood soon after traumatic brain injury by mature astrocytes. S100B is rapidly released into the cerebrospinal fluid and bloodstream after brain damage. We compared the serum concentrations of these proteins inpatients with severe head trauma (bleeding and/or fracture) or nontraumatic intracerebral hemorrhage and healthy individuals.Materials and Methods: The study included 63 patients (33 males and 30 females) with traumatic cerebral hemorrhage and/or cranial bone fractures or nontraumatic cerebral hemorrhage and 30 healthy control subjects. The reasons for attending the emergency department were as follows: fall from a heigh...
Background and Purpose: The brain-specific astroglial protein GFAP is a blood biomarker candidate in...
Contains fulltext : 50908.pdf (publisher's version ) (Closed access)Assessment of ...
About 1.7 million people suffer mild traumatic brain injury (TBI) annually (Faul et al., 2010). TBI ...
Both glial fibrillary acidic protein (GFAP) and S100β are found in glial cells and are released into...
Glial fibrillary acidic protein and its breakdown products (GFAP-BDP) are brain-specific proteins re...
Physical examination is the basic and most important tool in medical practice. However, at a neuroin...
Glial fibrillary acidic protein and its breakdown products (GFAP-BDP) are brain-specific proteins re...
Both glial fibrillary acidic protein (GFAP) and S100 beta are found in glial cells and are released ...
OBJECTIVE: To study the ability of glial (glial fibrillary acidic protein [GFAP] and S100b) and neur...
Glial fibrillary acidic protein (GFAP) is cleared by the Food and Drug Administration (FDA) to deter...
Objective: The biomarkers glial fibrillary acid protein (GFAP) and S100B are increasingly used as pr...
The incidence of head injury due to trauma increases the morbidity and mortality is relatively high,...
Objective: Identification and validation of blood-based biomarkers for the diagnosis and prognosis o...
Reliable diagnosis of traumatic brain injury (TBI) is a major public health need. Glial fibrillary a...
The purpose of this study was to correlate the early levels of glial fibrillary acidic protein (GFAP...
Background and Purpose: The brain-specific astroglial protein GFAP is a blood biomarker candidate in...
Contains fulltext : 50908.pdf (publisher's version ) (Closed access)Assessment of ...
About 1.7 million people suffer mild traumatic brain injury (TBI) annually (Faul et al., 2010). TBI ...
Both glial fibrillary acidic protein (GFAP) and S100β are found in glial cells and are released into...
Glial fibrillary acidic protein and its breakdown products (GFAP-BDP) are brain-specific proteins re...
Physical examination is the basic and most important tool in medical practice. However, at a neuroin...
Glial fibrillary acidic protein and its breakdown products (GFAP-BDP) are brain-specific proteins re...
Both glial fibrillary acidic protein (GFAP) and S100 beta are found in glial cells and are released ...
OBJECTIVE: To study the ability of glial (glial fibrillary acidic protein [GFAP] and S100b) and neur...
Glial fibrillary acidic protein (GFAP) is cleared by the Food and Drug Administration (FDA) to deter...
Objective: The biomarkers glial fibrillary acid protein (GFAP) and S100B are increasingly used as pr...
The incidence of head injury due to trauma increases the morbidity and mortality is relatively high,...
Objective: Identification and validation of blood-based biomarkers for the diagnosis and prognosis o...
Reliable diagnosis of traumatic brain injury (TBI) is a major public health need. Glial fibrillary a...
The purpose of this study was to correlate the early levels of glial fibrillary acidic protein (GFAP...
Background and Purpose: The brain-specific astroglial protein GFAP is a blood biomarker candidate in...
Contains fulltext : 50908.pdf (publisher's version ) (Closed access)Assessment of ...
About 1.7 million people suffer mild traumatic brain injury (TBI) annually (Faul et al., 2010). TBI ...